In the treatment of breast cancer, the uptake of certain drugs, such as albumin-paclitaxel and trastuzumab-metan conjugate (T-DM1), depends on Cav-1-mediated selective endocytosis (Chatterjee et al., 2017; Chung et al., 2018). The gene discussed is ALB; the disease is breast carcinoma.